What Amazon Sellers Need to Know About Dietary Supplement Compliance
Amazon now mandates pre‑approval for dietary‑supplement listings, requiring recent invoices, a COA for each SKU and cGMP certificates. Sellers must match the Supplement Facts panel exactly and avoid prohibited ingredients like DMAA; non‑compliance can trigger delisting within a 48‑hour response window.
Overview
Amazon’s marketplace treats dietary supplements as a high‑risk category, requiring sellers to meet both U.S. federal regulations and Amazon’s internal policies. Non‑compliance can trigger immediate listing removal, inventory disposal, or even suspension of the seller account, making adherence essential for anyone offering vitamins, minerals, botanicals, or similar products.
Key Points
- FDA compliance required — Every supplement must follow the Dietary Supplement Health and Education Act (DSHEA) and adhere to cGMP standards outlined in 21 CFR Part 111; a seller offering a probiotic capsule must have a manufacturing facility that passes FDA‑approved good‑manufacturing audits.
- Exact label matching — The Supplement Facts panel, ingredient list, and any claim on the Amazon detail page must mirror the physical label; for example, a whey protein powder advertised with “2 g of BCAAs per serving” must show the same amount on the bottle.
- Restricted ingredient enforcement — Amazon maintains a live list of prohibited and restricted substances; a product containing DMAA will be automatically suppressed regardless of the seller’s description.
- Documentation on demand — Amazon can request a Certificate of Analysis (COA), third‑party test results, or cGMP certificates at any point; failure to provide a COA for a herbal tincture within the stipulated response window can lead to immediate delisting.
- New‑seller gating — Fresh accounts must obtain category approval before listing any supplement, which involves submitting recent invoices, compliance paperwork, and high‑resolution product images for review.
- Claim limitations — Disease‑treatment language such as “cures arthritis” is prohibited, while structure‑function statements like “supports joint flexibility” are allowed if they are truthful and not misleading.
How Amazon’s Dietary Supplement Compliance System Works
- Pre‑listing screening — When a seller creates a new supplement listing, Amazon’s automated parser checks the title, bullet points, and description for prohibited keywords (e.g., “treats cancer”). If a seller lists a melatonin tablet with the claim “helps you sleep better,” the system flags it for review because “helps you sleep” is a structure‑function claim that requires careful wording.
Analysis & Recommendations
Why This Matters
Failure to meet the new requirements can result in immediate ASIN suppression, inventory disposal, or account suspension, costing sellers sales and reputation. Maintaining a digital COA library and monitoring Amazon's weekly restricted‑ingredient list prevents costly removals and keeps listings active.
Key Takeaways
- Amazon’s new framework requires category approval before any supplement can go live, with recent invoices and COAs submitted via Seller Central.
- Restricted‑ingredient database is live; products containing DMAA, ephedra or newly added synephrine are instantly blocked.
- Documentation requests must be answered within 48 hours or the listing is delisted, making a searchable COA repository essential.
- Structure‑function claims are allowed (e.g., "supports joint flexibility") but disease‑treatment language (e.g., "cures arthritis") is prohibited.
Recommended Actions
- →In Seller Central, go to Inventory > Manage Inventory and audit each supplement listing for prohibited keywords and exact label matching.
- →Upload a COA and cGMP certificate for every SKU in Seller Central > Performance > Account Health > Compliance Documents.
- →Subscribe to Amazon’s compliance notifications and weekly check the restricted‑ingredient list under Seller Central > Help > Policy Updates.
Comments
Join the discussion
Log in or create an account to share your thoughts on this update.
No comments yet. Be the first to share your thoughts!